Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients

Only about one third of non—small-cell lung cancer (NSCLC) patients respond to cisplatin-based chemotherapy. Cisplatin DNA adducts are commonly repaired through the nucleotide excision repair pathway. The study of rare inherited disorders such as xeroderma pigmentosum and Cockayne syndrome has discl...

Celý popis

Podrobná bibliografie

Vydáno v:	Clinical lung cancer Ročník 4; číslo 4; s. 237 - 241
Hlavní autoři:	Camps, Carlos, Sarries, Carmen, Roig, Bárbara, Javier Sánchez, José, Queralt, Cristina, Sancho, Eva, Martinez, Natividad, Tarón, Miguel, Rosell, Rafael
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.01.2003
Témata:	Chemotherapy resistance Cockayne syndrome DNA adducts DNA repair ERCC1 Transcription-coupled repair Xeroderma pigmentosum genes Cockayne syndrome Chemotherapy resistance ERCC1 DNA adducts DNA repair Transcription-coupled repair Xeroderma pigmentosum genes
ISSN:	1525-7304, 1938-0690
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!